Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 2000: 57: 178 -196. © Munksgaard, 2000 The present study is based on the proposal that complex disorders resulting from the effects of multiple genes are best investigated by simultaneously examining multiple candidate genes in the same group of subjects. We have examined the effect of 20 genes for dopamine, serotonin, and noradrenergic metabolism on a quantitative score for attention deficit hyperactivity disorder (ADHD) in 336 unrelated Caucasian subjects. The genotypes of each gene were assigned a score from 0 to 2, based on results from the literature or studies in an independent set of subjects (literature-based scoring), or results based on analysis of variance for the sample (optimized gene scoring). Multivariate linear regression analysis with backward elimination was used to determine which genes contributed most to the phenotype for both coding methods. For optimized gene scoring, three dopamine genes contributed to 2.3% of the variance, p = 0.052; three serotonin genes contributed to 3%, p =0.015; and six adrenergic genes contributed to 6.9%, p = 0.0006. For all genes combined, 12 genes contributed to 11.6% of the variance, p =0.0001. These results indicate that the adrenergic genes play a greater role in ADHD than either the dopaminergic or serotonergic genes combined. The results using literature-based gene scoring were similar. An examination of two additional comorbid phenotypes, conduct disorder and oppositional defiant disorder (ODD), indicated they shared genes with ADHD. For ODD different genotypes of the same genes were often used. These results support the value of the simultaneous examination of multiple candidate genes.
The present study is based on the proposal that complex disorders resulting from the effects of multiple genes are best investigated by simultaneously examining multiple candidate genes in the same group of subjects. We have examined the effect of 20 genes for dopamine, serotonin, and noradrenergic metabolism on a quantitative score for attention deficit hyperactivity disorder (ADHD) in 336 unrelated Caucasian subjects. The genotypes of each gene were assigned a score from 0 to 2, based on results from the literature or studies in an independent set of subjects (literature-based scoring), or results based on analysis of variance for the sample (optimized gene scoring). Multivariate linear regression analysis with backward elimination was used to determine which genes contributed most to the phenotype for both coding methods. For optimized gene scoring, three dopamine genes contributed to 2.3% of the variance, p = 0.052; three serotonin genes contributed to 3%, p =0.015; and six adrenergic genes contributed to 6.9%, p = 0.0006. For all genes combined, 12 genes contributed to 11.6% of the variance, p =0.0001. These results indicate that the adrenergic genes play a greater role in ADHD than either the dopaminergic or serotonergic genes combined. The results using literature-based gene scoring were similar. An examination of two additional comorbid phenotypes, conduct disorder and oppositional defiant disorder (ODD), indicated they shared genes with ADHD. For ODD different genotypes of the same genes were often used. These results support the value of the simultaneous examination of multiple candidate genes. Attention deficit hyperactivity disorder (ADHD) is the most common behavioral disorder affecting children. Recent twin studies have indicated that 75 to 90% of the variance of ADHD is attributable to additive genetic factors (1 -6) . Some of the specific genes involved are just beginning to be identified. They include the dopamine D 2 receptor (DRD2) (7, 8) , dopamine D 4 receptor (DRD4) (9) (10) (11) (12) , dopamine D 5 receptor (DRD5) (13) , dopamine transporter (DAT1) (14, 8, 15, 16, 13) , dopamine b-hydroxylase (8, 13) , adrenergic a2A (17), adrenergic a2C (18) , and monoamine oxidase A (17) .
David E Comings
Some studies for these genes have been negative (19) . Most complex behavioral disorders are inherited as polygenic traits interacting with the environment. A major characteristic of polygenic inheritance is that multiple genes are involved, with each gene contributing a small effect. The effects can be additive, heterotic (over-dominant), or epistatic. While numerous examples of epistasis have been reported, the additive effects and heterotic effects are considered to be predominant (78) (79) (80) . A phenotypic effect is obtained when an individual in-herits enough of these genes to exceed a threshold that puts them at increased risk of expressing a given trait (20) . The major implications of such a model are that studies that examine one gene at a time provide an incomplete picture, and tend to produce a series of both successful and unsuccessful attempts at replication. The present study is based on the assumption that the most effective way to identify the individual genes and groups of genes for disorders that are due to the additive effect of multiple genes is to study the additive effect of multiple candidate genes.
This concept arose out of our prior studies in which we examined the additive effect of three dopamine genes on a range of phenotypic traits, including ADHD in Tourette syndrome probands and controls. The three genes were the dopamine D 2 receptor gene (DRD2), the dopamine b-hydoxylase gene (DBH), and the dopamine transporter gene (DAT 1) (8) . In a subsequent study, we examined the additive effect of three adrenergic genes, DBH, ADRA2A and ADRA2C (17) . In both studies, each gene was scored on the basis of whether the individual carried the genotype that was associated with a given phenotype (score=1), or whether it was not associated with the phenotype (score=0). When the gene scores for each individual were added to form a composite polygenic (PG) score, that score could range from 0 to 3. The magnitude of quantitative traits for subjects carrying none, one, two, or all three of the genetic variants was examined by linear analysis of variance (ANOVA). For both the dopaminergic and adrenergic genes there was a significant increase in the magnitude of the traits in individuals carrying increasing numbers of the relevant gene variants. In a similar fashion, Pastinen et al. (21) analyzed common variants of eight genes implicated previously as risk factors for coronary heart disease. They identified two independent genes that were additive in their effect such that the odds ratio was 4.5 (p=0.001) for individuals carrying three or four of the risk-increasing alleles, compared to those carrying none or one such allele. Noble et al. (22) reported an additive effect of the DRD2 and GABRB3 genes on alcoholism. When severe alcoholics were compared to controls the odds ratio was 8.0 for the DRD2 Taq I A1 allele, 4.2 for alleles of a repeat polymorphism of the GABRB3 gene, and 36.9 for those carrying the risk alleles of both genes.
As we began to elaborate on this concept by adding more genes, we found that a superior approach was to examine the correlation coefficient, r, between the individual gene scores and any phenotypic trait. This approach allowed the determination of r 2 or the percent of the variance accounted for by the genes being examined, F, and the p value or significance of the correlation. Since all analyses were reduced to r 2 with a constant range from 0 to 1, this approach allowed for the comparison of quantitative traits of varying magnitudes. The cumulative effect of multiple genes could be determined on the basis of the magnitude of r 2 .
Issues in studying multiple genes
Studies of the combined effect of multiple genes raise a number of issues that may not be encountered when genes are examined singly. These issues are the following: 1) scoring of the genes; 2) the relative versus the absolute effect of different individual genes and functional sets of genes; 3) the use of neutral polymorphisms; 4) the handling of Xlinked genes; 5) the method of statistical analysis; and 6) analysis of comorbid disorders.
Scoring of the genes. In order to determine r 2 using linear regression analysis, it was necessary to score each gene according to the relative effect of the genotypes on the phenotype in question. To incorporate all the potential genotypes, based on the presence of two alleles (i.e. genotypes 11, 12, and 22) , the range of the gene scoring was increased from 0 to 1 in the studies cited above to 0-2. The score for the 11 genotype is on the left; the score for the 12 genotype is in the center; and the score for the 22 genotype is on the right. Thus, if the 11 genotype is associated with the lowest phenotype score, the 12 genotype with an intermediate score, and the 22 genotype with the highest genotype Table 1. The 12 types of possible gene scores based on 0-2 range,  assuming two alleles or allele groups   11  22  12   Dominant  1 allele dominant  2  2  0  2 allele dominant  0  2  2  Codominant  1 allele codominant  0  2  1  2 allele codominant  1  2  0  Recessive  1 allele recessive  2  0  0  2 allele recessive  0  0  2  Positive heterosis  Full positive heterosis  0  2  0  Partial positive heterosis 1  1  2  0  0  2  1  Partial positive heterosis 2  Negative heterosis  2  0  2  Full negative heterosis  Partial negative heterosis 1  2  0  1  2  0  1  Partial negative heterosis 2 score, the three genotype scores would form a total gene score of 012 (see 2 allele codominant in Table  1 ). If a polymorphism had multiple alleles, they were placed into two allele groups and three genotype groups. We have previously presented the rationale for segregating microsatellite polymorphisms into larger (L) versus smaller (S) alleles in this fashion to form three genotype groups, SS, LS and LL (23) . Table 1 shows the 12 different types of possible gene scoring. The method of determining the scoring of the genes is a critical issue. In order to prevent problems with compounding chance effects, the most obvious method is for the scoring to be based on prior studies in the literature. For example, if several papers in the literature showed an association of the 11 and 12 genotypes of gene X with ADHD, the literature-based gene score would be 220. However, there are a number of limitations to this approach: the results in the literature are often contradictory; the individuals studied may be of a different ethnic or racial background; the phenotypes studied may not be totally comparable; and more seriously, for many new genes there are no prior relevant studies. A second method that eliminates some of these problems is for the investigator to use one group of subjects to determine the method of coding the genes, and a second independent set of subjects to examine the combined effect of multiple genes. However, since both the initial and the re-test group may not have been evaluated by the same instrument, or since the number of subjects may be limited, this may not be a satisfactory solution.
The relati6e 6ersus the absolute effect of different indi6idual genes and functional sets of genes. The concern about the scoring of the genes is only an issue when the question is, 'What is the absolute percent of the variance accounted for by a given gene or group of genes?' Since the method of scoring can have a major effect on the resultant r 2 , scoring based on independent studies may be critical. However, a different question is: 'What is the relative percent of the variance accounted for by a given gene, or a functionally related group of genes?' Here the effect of each gene is optimized if the method of scoring is based on assessment of the relative effect of the three genotypes by ANOVA, in the same set of subjects that are used for testing the composite effect of multiple genes. If each gene score is optimized in this fashion (optimized gene scoring), on average, those genes that have the greatest physiologic effect will show the greatest relative impact on the phenotype compared to those genes with little or no effect. In other words, despite optimization of the gene scoring, and despite the impact of random results when the effect sizes are small, genes making little or no contribution to the genotype will tend to show a relatively smaller r 2 than those that contribute the most to the phenotype. Thus, when the issue is the examination of the relati6e effect of single genes or groups of genes, the sample used for gene scoring and the sample used for analyzing the combined effect of multiple genes can be the same sample.
Neutral polymorphisms. A number of the polymorphisms used in this study were single nucleotide polymorphisms (SNPs) that did not involve functionally relevant portions of the respective genes. We have previously proposed that since polygenic disorders are common and result from the combined effect of multiple genes, the genetic variants involved are unique in that they must be very common and must have only a minor effect on gene function (24, 23, 25, 26) . We have also suggested that the varying lengths of the common microsatellite polymorphisms are responsible for much of this variation, through the formation of varying lengths of Z-DNA, which modulates gene function (23) . A corollary of this is that each gene may be associated with a wide range of hypo-and hyper-functional variants, and that any common SNP, whether in a functional region of the gene or not, is likely to divide the gene into groups that vary in their phenotypic effect (25) .
Handling of X-linked genes.
With experience, we found that unless the gender composition of the controls and subjects was virtually identical, the results for X-linked genes were likely to be inaccurate. Since this was not the case for this database, X-linked genes were excluded.
The method of statistical analysis. In the present manuscript, we have used multivariate linear regression analysis with backward elimination to examine the composite effect of multiple genes. Three groups of genes were studied: six dopamine genes (DRD1, DRD2, DRD3, DRD4, DRD5, and DAT1), seven serotonin genes (HTT, HTR1A, HTR1B, HTR1DA, HTR2A, TDO2 and TRH), seven noradrenergic genes (DBH, ADRA2A, ADRAB, ADRA2C, PNMT, NET and COMT), and the total of all 20 genes together. We call this a multivariate analysis of associations (MAA) technique.
Analysis of comorbid disorders.
A further advantage of this technique is that if the subjects are systematically evaluated at a range of phenotypes, especially those that are likely to be comorbid with the primary phenotype, the relative importance of individual genes or functional groups of genes can also be examined for those phenotypes. This allows for the testing of the hypothesis that comorbid conditions are present because they share some of the same genes (24, 26) . We have examined conduct disorder (CD) and oppositional defiant disorder (ODD), two conditions that are commonly comorbid with ADHD (27 -29) .
In summary, the comparison of the effect of multiple genes on a phenotypic variable taps into the major characteristics of polygenic inheritancethe additive, epistatic and heterotic effect of multiple genes. In addition, it taps into the fact that while a number of different genes may be contributing to a given phenotype in the general population, the effects of only a subset of those genes may be in evidence in any given individual or group of individuals, i.e. genetic heterogeneity. The combination of small effect size and genetic heterogeneity often results in problems with replication when genes are studied singly. Examining and comparing the effect of multiple genes and functional groups of genes may compensate for the presence of different sets of genes in different individuals with the same phenotype. Since the MAA technique can assess the effect of groups of genes, it may be more reproducible across different groups of subjects. To give a specific example, while variants of the DRD2 (Taq I A1 allele) (8), DRD4 (48 bp 7 repeat) (9 -12), DRD5 (13), and DAT1 (10 repeat allele) genes (8, 14 -16) have all been implicated in the etiology of ADHD, each may have a significant effect in one group of subjects, but not in others. However, if the physiologic effect is similar for each gene (alteration in dopamine metabolism), the combined effect of all these genes might prove to be more replicable across different groups of ADHD subjects, indicating that it is a global dysregulation of dopamine metabolism rather than any single gene that is etiologically important in ADHD. In addition, by comparing the relative effect of different genes in a single group of subjects, one might find that genes affecting a different neurotransmitter, such as norepinephrine, have a greater relative effect on ADHD than dopamine genes.
In the present study we have used these approaches to answer the following questions: Are dopaminergic, serotonergic or noradrenergic genes more important in ADHD? Are similar or different genes utilized in comorbid disorders such as CD and ODD?
Methods Subjects
The TS group consisted of 336 unrelated, non-Hispanic, Caucasian subjects. Of these, 274 had a diagnosis of Tourette syndrome (TS) and 62 were controls. The TS subjects came from the Tourette syndrome Clinic at the City of Hope Medical Center. All met the criteria of the Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-IV) for TS, and all were personally interviewed by DE Comings. Among the TS subjects 30% were severe, 62% were moderate, and 8% were mild in severity. TS and ADHD are similar disorders, and the majority of TS subjects that come to clinics have comorbid ADHD (30, 31) . Of the TS subjects, 54% met DSM-IV criteria for ADHD. The age of the TS subjects averaged 18 years (SD 13.2). While the majority were older children and adolescents, 29% were 21 years of age or older. The controls were unrelated adopting or foster parents of the TS probands. These had the advantage that they were of the same geographic, ethnic, and socioeconomic status as the probands, and were motivated to participate and could be interviewed at the same time as the probands. The mean age of the controls was 46.3 years (SD 15.38).
Our clinical studies of over 3000 TS probands indicate that ADHD with chronic tics (TS) is very similar to ADHD without tics (32, 33) . Thus, ADHD in TS subjects is especially suitable for molecular genetic studies since both are strongly genetic disorders. Since TS (34) is commonly associated with a range of other comorbid disorders, this group is also suitable for studying the role of multiple genes in various comorbid disorders.
To aid in the clinical evaluation and diagnosis and ensure that all DSM criteria were reviewed in a structured fashion, we utilized a questionnaire based on the Diagnostic Interview Schedule (35) and DSM-IV (36) criteria for a range of disorders. For the ADHD score, the questions asked if each of the DSM-IV ADHD criteria during childhood and adolescence were never or rarely present (score =0), occasionally present (score=1), or always present (score=2). The final ADHD score for each subject represented the sum of the above scores for each of the DSM-IV criteria. The subjects were also asked the same questions about each of the DSM-IV ADHD criteria for ODD and CD. These subjects and the clinical scores have been described in detail elsewhere (8, 34, 37, 38) . Each subject was also personally interviewed by DE Comings to ensure the accuracy of the responses and of the clinical diagnoses. In the present study, the distribution of ADHD scores ranged from 0 to 34 with a mean of 18.1, a median of 19.5 and a SD of 10.9. Skewness was −0.21. Kurtosis was −1.29 indicating a platykurtotic distribution. The minimum conduct score was 0.0 and the maximum 12.0, with a mean of 3.25, a median of 3.0, a standard deviation of 2.56, a skewness of 0.74, and kurtosis of −0.1542, indicating the peak was skewed to the lower scores. The minimum ODD score was 0.0 and the maximum was 9.0, with a mean of 3.62, a median of 3.0, a standard deviation of 3.2, a skewness of 0.28, and kurtosis of − 1.36, indicating a platykurtic distribution. As with the ADHD score, the continuous phenotypic scores for ODD and CD were based on questions from a questionnaire that asked if each of the DSM-IV ADHD symptoms for ODD and CD during childhood and adolescence were never or rarely present (score=0), occasionally present (score=1), or always present (score=2). The final ODD and CD scores for each subject represented the sum of the above scores for each of the DSM-IV ODD or CD criteria.
Polymorphisms
The references for the literature-based gene scoring and the techniques for determining the polymorphisms are given in Table 2 . We recently identified two polymorphisms in our laboratory for this study, at the HTR1A and PNMT genes.
HTR1A gene. While a number of SNP polymorphisms have been reported for the HTR1A gene, the gene frequencies are too low to be useful (39) (40) (41) . However, we have identified a common C-1918G SNP in the 5' region of the HTR1A gene (42) .
PNMT gene. The phenylethanolamine methyl transferase gene (PNMT) is responsible for the conversion of norepinephrine to epinephrine. We identified two SNPs at the PNMT gene, G-148A and G-353A (43) . We utilized the G-148A polymorphism.
Genotyping
All genotyping was done by polymerase chain reaction (PCR). The polymorphisms used and the methods for genotyping are given in Table 2 . The descriptions of the two polymorphisms developed in our laboratory are given above. Microsatellite polymorphisms were genotyped using fluorescent labeled PCR products in which 0.1 mM of each primer was labeled with fluorescent HEX or FAM Amidite (Applied Biosystems, Foster City, CA). Following PCR, the denatured products were loaded on a 6% polyacrylamide gel in an Applied Biosystems 373 DNA sequencer. The gel was electrophoresed for 5 h at 1100 volts and a constant 30 W. The gel was laser scanned and analyzed using the internal ROX 500 standards. The peaks were recognized by Genotyper (version 1.1) (Applied Biosystems), based on the color fragments sized by base-pair length.
Gene scores
The 12 possible methods of scoring three genotypes of any gene are shown in Table 1 . For comparison purposes, we have used two sets of gene scores, those based on the results in the literature (lit), or our own studies of an independent (ind) group of subjects with ADHD or a similar impulse disorder, and those based on optimized scores. The optimized gene scores were based on results of ANOVA, comparing the means of the ADHD score for the three genotypes. Since these were performed on the same set of subjects used for the regression analyses, they are termed optimized scores. Table 2 shows both the 'literature' scores and the 'optimized' scores.
Random scores
To examine the possibility that, when examined, multiple genes might also have a significant effect on a random ADHD score, a random ADHD score was derived using the RV.normal (mean, SD) function of SPSS (SPSS, Inc, Chicago, IL). The mean and SD of the observed ADHD score were used. We examined the mean of a total of 500 such simulations. We also examined two single random scores to ensure that the results were similar to those obtained with the mean of 500 random ADHD scores. For all three of these random scores, ANOVA was performed for each gene, and the genotype with the highest scores was given a genotype score of 2, the genotype with the lowest scores was given a genotype score of 0, and the third genotype was scored 0 or 1, depending on whether it was intermediate or closer to the 0 or the 2 genotype. These formed the optimized gene scores for the random ADHD scores.
Statistics
For optimized gene scoring, ANOVA was used. The relative magnitude of the mean ADHD score for each genotype was used to determine the scoring. Multivariate linear regression analysis with backward elimination was used to examine the correlation between the gene scores and the ADHD score, using the ADHD score as the dependent variable, with the gene scores as the independent variables. In backward elimination, all gene scores are added together and removed one at a time based on the removal criteria. The in p value was set at 0.1 and the out p value (p criteria for removing a variable) was set at 0.2. The SPSS statistical package (SPSS, Inc, Chicago, IL) was used. Table 2 , of the 20 genes tested, the 'literature' gene scoring was based on the literature in 12 cases, and on our own independent studies in eight cases. Since the dopamine genes have been the most extensively studied, all of these were based on the literature. Since two of the polymorphisms, those for the HTR1A and PNMT genes, were recently developed in our laboratory, they were of necessity based on our own independent studies. The results for the multivariate analyses comparing the results based on the 'literature' and the 'optimized' gene scoring are shown in Table 3 .
Results

As shown in
Dopamine genes
The literature and optimized scorings were the same for the DRD1 and DAT1 genes, differed slightly for the DRD2 gene, more so for the DRD3 gene (002 instead of 202), and most of all for the DRD4 gene (200 instead of 002). Using literaturebased gene scoring, three dopamine genes, DAT1, DRD2, and DRD5, were retained in the regression equation. Each accounted for 0.64 to 0.77% of the variance; the p values for each were in the 0.14-0.10 range, and when combined, they accounted for 2.2% of the variance of the ADHD score; p= 0.057. The same three genes were retained for the optimized gene scoring, DAT1, DRD2, and DRD5. The percentages of the variances were similar (0.61-0.83); the p values were similar (0.093-0.15), and the total percent of the variance accounted for by the three genes was similar, 2.3%; p=0.052. When the random ADHD score was tested, none of the genes was retained.
Serotonin genes
For the serotonin genes, the literature gene scoring was the same as the optimized scoring for the HTR1DA and TDO2 genes, similar for the HTT and HTR1B genes, and different for the HTR1A, HTR2A and TPH genes. Using the literature/independent study gene scoring, only a single gene, HTT, was retained in the equation. It accounted for 1.0% of the variance; p=0.064. Using the optimized gene scoring, three genes, HTT, HTR1A and TPH, were retained. They accounted for 0.076-1.23% of the variance with p values of 0.041 to 0.108. Combined, they accounted for 3.09% of the variance; p=0.015. Again, when the random ADHD score was tested, none of the genes was for the individual genes that were included in the multivariate regression equations, the r 2 for the dopamine, serotonin and noradrenaline genes combined, the dopamine + serotonin genes, and all genes combined for the literature/independent gene scoring, the optimized gene scoring, and the random ADHD score.
retained. When the dopamine and serotonin genes were combined, they accounted for 3.15% of the variance in literature gene scores (p= 0.031) and for 5.04% of the variance for optimized gene scores (p =0.0089).
Adrenergic genes
For the adrenergic genes, the literature/independent study gene scoring was the same as the optimized scoring for the DBH, ADRA2A, NET, and COMT genes, and similar for the ADRA2B, ADRA2C, and PNMT genes. Using the literature/ independent study gene scoring, five adrenergic genes, ADRA2C, ADRA2A, COMT, NET, and DBH, were retained in the equation. They accounted for 0. 
All genes
When all three functional groups of genes were combined, using the literature/independent group Fig. 2 . The percent of the total variance for all 20 genes that were due to the dopamine, serotonin and noradrenaline genes individually for the literature/independent study gene scoring, and the optimized gene scoring. Fig. 3 . The results using optimized gene scores based on ANOVA of the ADHD, ODD and CD scores, respectively, and using multivariate regression analysis with backward elimination to identify the genes to be included. The results for all three sets of dopamine, serotonin, and noradrenaline genes, and the total genes were similar when two single sets of random ADHD scores were examined. Fig. 1 shows the r 2 results for the three different groups of genes, the dopamine+ the serotonin, and all genes together. Fig. 2 shows the percent of the total variance for all 20 genes that is accounted for by the dopamine, serotonin and noradrenaline genes individually. This shows that the results were similar for both the literature/independent studies and the optimized gene scoring techniques in that the noradrenaline genes accounted for 65 and 56%, respectively, of the total variance for the genes studied.
To examine the role of varying the parameters for the multiple regression model, the pout was set at progressively higher values from 0.2 to 0.8. At pout =0.3, the HTR1B gene was added and r 2 = 0.345, and at pout =0.4 the HTR1DA gene was added and r 2 =0.349. Further increases in pout produced trivial increases in r 2 and increases in p values. An additional potential concern is that forcing the genes into a 0, 1 and 2 scoring may not be appropriate for all genes. Some genes might be more accurately represented by fractional gene scores such as 0, 0.2, and 0.4. However, when fractional gene scores based on the precise relative differences in the magnitude of the means were used, the results were not significantly improved over those obtained with the random ADHD score using the same approach. The comparative role of different genes for ADHD, ODD, and CD is shown in Fig. 3 . Optimized gene scores were used for all three variables. The specific genes that are involved and the magnitude of the involvement (r 2 ) can be seen at a glance. The role of the DRD2 gene in CD, the lesser role of serotonin genes in CD, and the major role of the noradrenergic genes for all three traits, are apparent.
To examine the relative percent of each functional group of genes, we plotted the percentages of the total r 2 attributed to each group. These results are shown in Fig. 4 . For ADHD, the dopamine, serotonin, and noradrenaline genes accounted for 19, 23, and 58%, respectively, of the variance of the 20 genes. For ODD the respective values were 21, 34 and 45%, indicating that serotonin genes were more involved and noradrenergic genes slightly less involved in ODD than ADHD. For CD, the respective values were 39, 9, and 52%, suggesting that noradrenergic genes were involved in CD, but that dopamine genes were playing a greater role than serotonin genes.
Discussion
One of the most consistent aspects of studies of the role of individual genes in polygenic disorders is that they are almost never uniformly replicated across all reports. When population-based casecontrolled association studies are used, these differences are often blamed on hidden ethnic stratification. However, this lack of uniform replication is just as common in family-based studies (transmission disequilibrium test), suggesting that genetic heterogeneity and small effect size are the primary causes of poor replication. If 100 different genes can contribute to a given phenotype, but only 10-20 are required to pass a threshold for clinical expression in a given individual, variability from study to study would be the expected outcome of studies of polygenic disorders. One of the goals of the present study is to examine the possibility that replication between studies might be increased by examining the additive effect of multiple genes rather than focusing on single genes.
Dopamine genes
The DAT1, DRD2, and DRD5 genes were included in the equation for both the literature gene scoring and the optimized gene scoring. The DAT1 is a particularly important candidate gene for ADHD because it is the site of action of methylphenidate and dextroamphetamine (44) , the two most widely used treatments for ADHD; a number of studies have implicated the 10 allele of this gene in ADHD (8, 13, 14, 16 ). In addition, knockout mice missing the DAT1 gene are very hyperactive (45) . The DRD2 gene has been implicated in a wide range of impulsive, compulsive and additive behaviors (46) . Using family-based association studies, Daly et al. (13) reported a significant (p B0.0005) preferential transmission of the 148 bp allele of the DRD5 dinucleotide polymorphism (47) to children with ADHD. Thus, these results are consistent with those in the literature. The \4 alleles of the DRD4 gene have also been implicated in ADHD in some (9, 11, 12, 48, 49) , but not all (19, 48, (50) (51) (52) studies. Based on optimized gene scoring, in this study, the 2 alleles showed more association with the ADHD score, but this was a very modest effect. Despite the wide implication for an important role of dopamine genes in ADHD, in the present study, when combined, and based on either the literature or optimized gene scoring, they accounted for only 2.3% of the variance of the ADHD score; p = 0.052.
Serotonin genes
Serotonin genes have not been previously implicated in ADHD. Using the literature or independent study gene scoring, only the HTT gene was included in the equation; p=0.064. By contrast, based on optimized scoring, the HTR1A and TPH genes were also included.
Adrenergic genes
We were particularly interested in examining the role of adrenergic genes in ADHD because ADHD is a disorder of cognition and arousal (53, 54) ; noradrenaline is closely linked to both (55) (56) (57) . In addition, there are many interactions between dopamine and noradrenaline neurons in the brain (58) . The ADRA2A and ADRA2C genes were especially important because they represent the site of action of clonidine (59-61), a medication that is effective in the treatment of ADHD (62) and Tourette syndrome (63) . In addition, these receptors have been shown to be involved in normal frontal lobe function (59, 60) . Aston-Jones (64) has correlated ADHD with tonic as opposed to phasic firing of the norepinephrine neurons in the locus coeruleus. Tonic firing in experimental animals correlates with distractibility, short attention span, hyper-reactivity, low frustration tolerance, and anxiety seen in ADHD subjects. All the major medications used to treat ADHD (methylphenidate, dextroamphetamine, desipramine, and clonidine) have a significant effect on modulating the tonic firing of norepinephrine neurons.
We were interested in the phenylethanolamine-N-methytransferase (PNMT) gene because it is responsible for the conversion of norepinephrine to epinephrine, and epinephrine abnormalities have also been implicated in ADHD (65, 66) . It was, thus, of interest that for literature/independent gene scoring, all five of the noradrenergic genes were retained in the equation, and with optimized scoring, six -including the PNMT gene -were retained. Combined, they accounted for 6.9% of the variance. This was three times the variance for the dopamine genes, and greater than the variance for the dopamine and serotonin genes combined. This is consistent with a significant role for norepinephrine genes in ADHD. Although we included COMT with the adrenergic genes, we recognize that it also plays a role in degradation of dopamine. When the COMT gene was removed, the remaining adrenergic genes still accounted for 5.8% of the variance, p =0.0013.
Heterosis
Heterosis or over-dominance refers to a situation in which a phenotype is greater for heterozygotes than for either homozygote. It is termed positive heterosis when the value is higher in heterozygotes and negative heterosis when the value is lower in heterozygotes. While heterosis is most commonly described in relation to uniform parental strains versus more vigorous hybrids (hybrid vigor), it can also occur at the level of individual molecular genetic polymorphisms. We have referred to this as molecular heterosis (67, 68) . Table 4 lists the gene scores for all of the genes for each of the three phenotypes. This shows that the distribution of the different possible gene scores and types of inheritance is random across the five general types of inheritance and the three phenotypes (chi square p =0.97). The proportion of each of the five types of inheritance that occurred ranged from 15 to 28%. When corrected for the number of possible types in each group (e.g. codominant divided by 2, and positive heterosis divided by 3), the range was even narrower, 6.7-9.3%. One of the types of heterosis occurred 48% of the time. This indicates that molecular heterosis is common and occurs in proportion to the frequency of the other types of inheritance.
Different phenotypes use different genes and different genotypes
When polygenic disorders are viewed as similar to single gene disorders except that a few more genes are involved, it would be anticipated that the dif-ferent phenotypes would be due to the involvement of different genes and that the gene scoring would remain constant for different phenotypes. However, when viewed from the perspective that polygenic disorders uniquely involve multiple gene variants rather than mutations, and that the gene scoring is sensitive to a number of factors, different phenotypes may be due to both different genes and the utilization of different modes of inheritance of each gene (Table 1) . We have observed this in our unpublished studies of the role of dopamine, serotonin, and noradrenaline gene in personality traits. The present results further illustrate this point. Thus, when ODD and CD were examined, using the same optimized gene scores as for ADHD (not shown), the total percent of the variance was lower for both ODD and CD. This was consistent with ODD and CD both sharing genes with ADHD and using a different set of genes than ADHD. However, when the optimized gene scores were used, the total percent of the variance for ODD increased to a level approaching that for ADHD, but remained low for CD. This is consistent with ODD sharing genes with ADHD but utilizing different genotypes for some genes, and with CD sharing fewer genes with ADHD, and using different genes rather than different genotypes of the same genes. Both the low percentage of the variance accounted for by each gene, and the use of different genotypes of the same genes, could account for much of the difficulty in identifying phenotype-specific genes using linkage analysis and family-based association studies when examining one gene at a time. 
Statistical issues
Concern has frequently been voiced about the difficulty of identifying the genes involved in polygenic disorders (69) . In the present study, we have attempted to turn the single major characteristic of polygenic disorders, the additive and heterotic effects of many different genes, to an advantage by examining more than one gene at a time. Since this is a new technique, it is reasonable to examine some of the statistical approaches that were used.
The first issue is that if the association studies used to determine the direction of the gene scoring were done on the same group of subjects, it would maximize the effect of each gene. However, it could also be argued that the maximization cannot of itself make a given gene contribute more to the total variance than any other gene. Apart from the role of random effects, a given gene must be more biologically associated with the phenotype than another gene in order to account for a greater percent of the variance. Thus, if the primary goal is to examine the relative effect of different genes or functional groups of genes, the use of optimized gene scores is valid. It is only when the goal is to accurately determine the absolute percent of the variance that gene scores based on the literature or independent studies are required. In addition, optimized gene scoring identifies an additional major aspect of polygenic inheritance, the use of different genotypes of the same genes in different phenotypes, on a background of other genes.
To allow us to compare the results of using literature/independent studies for gene scoring versus optimized gene scoring, we examined both. In these studies the results of the two were only modestly different. Thus, using literature/independent gene scoring, seven genes accounted for 8.08% of the variance (p=0.0002), while using optimized gene scoring, an additional five genes were included, accounting for 11.6% of the variance; p = 0.0001. All of the genes included for the literature or independent study gene scoring were included in the set for optimized gene scoring.
An additional caveat for this study, not directly related to statistical issues, is that ADHD in TS subjects was studied. Based on our 4000+ TS and ADHD patients, we have observed no significant differences between ADHD without tics versus ADHD with tics, and we believe the pathophysiology for motor hyperactivity is similar to the pathophysiology of tics (70) . Despite this, studies similar to this in ADHD without tics are needed. We would also recommend studies of ADHD limited to males, or the examination of males and females separately, to allow the accurate assessment of the relative role of X-linked genes such as the HTR1C, MAOA (71) , MAOB and androgen receptor (72) genes. Yet another caveat is that hidden ethnic stratification is a potential confounding factor in association studies. While this is often blamed for the erratic replication of studies when examining one gene at a time, we believe the low percent of the variance attributable to each gene and the considerable genetic heterogeneity of polygenic disorders is a more common culprit.
Implications for genetic studies of complex disorders
We believe these studies have a number of implications, not only for psychiatric genetics, but for the genetics of complex polygenic disorders in general.
The power of examining multiple as opposed to single genes. These studies provide some insight into the problems with the reproducibility of association studies that examine genes one at a time. This is most likely due to the fact that multiple genes are involved; no single gene is critical, and each gene contributes to only a small percent of the variance. As a consequence, when genes are examined one at a time, one gene may reach significance in one study but not in another. Rather than being the source of endless frustration (73) , this should be viewed as the expected outcome in the genetics of complex disorders (74) .
Use of different polymorphisms. In this study we used only one polymorphism per gene. The use of other polymorphisms, or the combination of several polymorphisms at each gene as haplotypes, would probably increase the r 2 values. Thus, the total r 2 values observed here may actually underestimate the true contribution of these genes.
An equal number of controls and subjects is ideal. As we have continued to examine the effect of multiple genes on different phenotypes it has become apparent that it is most powerful when the number of controls is comparable to the number of subjects. This maximizes the range of the phenotypic scores. In the present study, while the number of controls was less than the number of TS subjects, only half of the TS subjects had ADHD. Thus, in regard to high or low ADHD scores, the sample was approximately evenly divided.
Comparati6e effect of different groups of genes.
Another aspect of examining multiple genes in the same set of subjects is its ability to identify the important role of groups of genes affecting specific neurotransmitters for different phenotypes. Thus, the present study showed that noradrenergic genes played a greater role in the ADHD score than either the dopaminergic or the serotonergic genes, individually or combined. Together, they accounted for 56-65% of the total r 2 for all the genes examined. This is in agreement with the many studies strongly attributing defects in norepinephrine metabolism to ADHD (59, 64, 75, 76) . It could be argued that, for understanding the cause and treatment of behavioral disorder, this may be more important than identifying a role for individual genes.
Risk factors 6ersus diagnosis and predictability. One of the common assumptions about polygenic inheritance is that the genes involved act only as risk factors and, in contrast to single gene disorders, it will not be possible to use genetic tests in a diagnostic fashion. However, as the percent of the variance explained by the effect of multiple genes increases, there is an associated increase in predictability. The final optimized r of 0.34 for the ADHD score indicates that by using this set of genes, the predictability of the ADHD score was up to 34% greater than what it would have been with no genetic information. With the addition of still more genes, r values of twice this magnitude may be obtained. At that point, these multigene tests may begin to have some diagnostic value. The ability to perform hundreds of genotypes on DNA chips (77) has alleviated the problem of having to examine a large number of genes.
Replication. The multi-gene approach needs to be verified with further studies. Variations in the number of subjects, composition of probands by severity, the ratio of controls versus subjects, the number of polymorphisms per gene, the gender make-up of the sample, ethnicity, and other factors would all be expected to alter the final r 2 values, independent of the effect of specific genes themselves. Based on these factors, we would anticipate varying levels of replication. The highest level of replication is one in which the identical sets of genes are involved in different studies. Since the ability of different genes to produce a similar phenotypic effects is one of the characteristics of polygenic disorders, we anticipate that this level of replication is both unlikely and unexpected.
A second and more realistic standard of replication is one in which many, but not all, of the genes in one study are genes included in replication studies, and in which the r 2 values and significance levels progressively increase as more genes are included. At this level, it would also be expected that the relative importance of functional groups of genes, in this case the greater role of noradrenergic genes, would be replicated in different studies.
Use of different genotypes of the same genes. Since the variants in polygenic disorders may be associated with a modest increase or decrease in the function of the relevant gene (25) , since each gene has only a modest effect, and since there is considerable genetic heterogeneity, it is likely that, in addition to different genes being involved in different groups of subjects, different genotypes of the same gene may be involved in different phenotypes or in different subject groups. This is a likely explanation why studies in the literature do not always agree about which alleles are most associated with a given trait, and why there was not uniform agreement between the literature or independent study gene scoring and the optimized gene scoring.
Incorporation of en6ironmental 6ariables. Since the primary statistical approach is the use of regression analysis, the effect of environmental and other nongenetic variables can be partialled out and the regression analyses run on the residuals, or incorporated into a multivariate regression equation. This was done in a study of coronary artery disease by Pastinen et al. (21) . By logistic regression analysis, they demonstrated that the additive effect of two genes was not affected by the variables of sex, smoking, BMI, or serum lipids. Therapeutic and pharmacological implications. A final aspect of the multiple gene technique, based on its ability to both identify the genes involved and to weigh their relative importance, is its potential power to guide therapeutic and pharmacological interventions. For example, the observation that the adrenergic genes accounted for the majority of the final r 2 value of the ADHD score suggests that drugs acting on the adrenergic a 2 receptors would be of value in the treatment of ADHD. In fact, clinical studies support the effectiveness of clonidine and guanifacine, adrenergic a 2 receptor agonists, in the treatment of ADHD (62) .
Summary
The simultaneous examination of a number of genes is well suited for the identification of the genes involved in polygenic disorders because it addresses the primary characteristic of polygenic disordersthat multiple genes, each accounting for a small percent of the variance, have a combined effect on the phenotype. Since it utilizes the association technique, it can identify genes that account for as little as 0.5% of the variance, and yet is more likely to be replicable than association studies examining one gene at a time. The technique can be used for any phenotype, either as quantitative or dichotomous (using logistic regression) variables. Since all the genes are assessed in one group of subjects, it provides an estimate of the relative importance of individual genes and groups of genes with a similar function. It can incorporate environmental and other nongenetic variables. Finally, it is elegantly simple to understand; the computations are rapid and use off-the-shelf software. We believe this technique will be well suited to the use of DNA arraybased techniques that allow the simultaneous identification of alleles at many candidate loci in different polygenic disorders.
